Reproductive Organ Pathology of Individuals Undergoing Gender-Affirming Surgery.
Surg Pathol Clin
; 15(2): 421-434, 2022 Jun.
Article
en En
| MEDLINE
| ID: mdl-35715169
ABSTRACT
As gender-affirming surgeries become more routine, it is increasingly important for pathologists to recognize the expected histologic changes seen in various tissues secondary to gender-affirming hormone therapy. For example, exogenous testosterone-related squamous atrophy or transitional cell metaplasia of the cervix may be confused for high-grade squamous intraepithelial lesion. In addition to distinguishing between benign and dysplastic/malignant features, pathologists should be mindful of the phrasing of their reports and aim to use objective, nongendered language.
Palabras clave
Texto completo:
1
Bases de datos:
MEDLINE
Asunto principal:
Personas Transgénero
Límite:
Female
/
Humans
Idioma:
En
Revista:
Surg Pathol Clin
Año:
2022
Tipo del documento:
Article
País de afiliación:
Estados Unidos